ARTICLE | Clinical News
Simplirix: Development discontinued
November 1, 2010 7:00 AM UTC
GlaxoSmithKline discontinued development of HSV vaccine Simplirix after data from the double-blind, U.S. and Canadian Phase III Herpevac Trial for Women in 8,323 healthy volunteers ages 18-30 showed t...